Stages of Objective Memory Impairment Predict Alzheimer’s Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale – Sum of Boxes

Manuscript Number: 

20-0946R2

Author(s): 
Ellen Grober, Jason Hassenstab, Lynn Kuo, Richard B. Lipton, Richard J. Perrin, Qi Qi

Disclosures

Ellen Grober

  • Patents/Royalties
    I receive a small fee for commercial use of the Free and Cued Selective Reminding Test with Immediate Recall

Jason Hassenstab

  • Consulting Fees:
    Biogen-Consultant Takeda-Consultant Parabon Labs-Consultant Lundbeck-Advisory Board Roche-Advisory Board

Lynn Kuo

  • Nothing to Disclose

Richard B. Lipton

  • Consulting Fees:
    Merck - consulting fees, advisory board Grifols - consulting fees Eli Lilly - consulting fees, advisory board
    Equity:
    Biohaven CtrlM Health
    Grants
    • Agency: 
      S&L Marx Foundation
      Dates: 
      2012- present

Richard J. Perrin

  • Nothing to Disclose

Qi Qi

  • Nothing to Disclose